APO Research
Talk to an analyst

APO RESEARCH · REPORT

Lung AI-assisted Diagnosis Software

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Lung AI-assisted Diagnosis Software Market Analysis and Forecast 2026-2032

6 March 2026196 pages

Choose your research edition.

Industry ResearchLung AI-assisted Diagnosis Software Industry Research Report 2026115 pages · $2,950 USDIndustry Growth & TrendsGlobal Lung AI-assisted Diagnosis Software Industry Growth and Trends Forecast to 2032102 pages · $3,450 USDMarket StructureGlobal Lung AI-assisted Diagnosis Software Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Lung AI-assisted Diagnosis Software Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Lung AI-assisted Diagnosis Software Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

The global Lung AI-assisted Diagnosis Software market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Lung AI-assisted Diagnosis Software is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Lung AI-assisted Diagnosis Software is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Lung AI-assisted Diagnosis Software is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Lung AI-assisted Diagnosis Software is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Lung AI-assisted Diagnosis Software include Sense Time, United Imaging, Huiying Medical, Yizhun, BioMind, Shukun, Infervision, Deepwise and Optellum, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Lung AI-assisted Diagnosis Software, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Lung AI-assisted Diagnosis Software, also provides the revenue of main regions and countries. Of the upcoming market potential for Lung AI-assisted Diagnosis Software, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Lung AI-assisted Diagnosis Software revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Lung AI-assisted Diagnosis Software market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Lung AI-assisted Diagnosis Software revenue, projected growth trends, production technology, application and end-user industry.

Lung AI-assisted Diagnosis Software Segment by Company

Sense Time

United Imaging

Huiying Medical

Yizhun

BioMind

Shukun

Infervision

Deepwise

Optellum

IMLINCS

NeuMiva

Yitu

FOSUN AITROX

VoxelCloud

Lung AI-assisted Diagnosis Software Segment by Type

Public Cloud

Private Cloud

Lung AI-assisted Diagnosis Software Segment by Application

Hospital

Clinic

Imaging Center

Lung AI-assisted Diagnosis Software Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Lung AI-assisted Diagnosis Software market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Lung AI-assisted Diagnosis Software and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Lung AI-assisted Diagnosis Software.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Lung AI-assisted Diagnosis Software in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Lung AI-assisted Diagnosis Software company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Lung AI-assisted Diagnosis Software revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Lung AI-assisted Diagnosis Software Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Public Cloud Major Player Table 3. Private Cloud Major Player Table 4. Global Lung AI-assisted Diagnosis Software Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Hospital Major Player Table 6. Clinic Major Player Table 7. Imaging Center Major Player Table 8. Lung AI-assisted Diagnosis Software Industry Trends Table 9. Lung AI-assisted Diagnosis Software Industry Drivers Table 10. Lung AI-assisted Diagnosis Software Industry Opportunities and Challenges Table 11. Lung AI-assisted Diagnosis Software Industry Restraints Table 12. Global Lung AI-assisted Diagnosis Software Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 13. Global Lung AI-assisted Diagnosis Software Market Size by Region (2021-2026) & (US$ Million) Table 14. Global Lung AI-assisted Diagnosis Software Market Share by Region (2021-2026) Table 15. Global Lung AI-assisted Diagnosis Software Market Size by Region (2027-2032) & (US$ Million) Table 16. Global Lung AI-assisted Diagnosis Software Market Share by Region (2027-2032) Table 17. Global Lung AI-assisted Diagnosis Software Revenue by Players (US$ Million) & (2021-2026) Table 18. Global Lung AI-assisted Diagnosis Software Revenue Market Share by Players (2021-2026) Table 19. Global Lung AI-assisted Diagnosis Software Key Players Ranking, 2024 VS 2025 VS 2026 Table 20. Global Lung AI-assisted Diagnosis Software Key Players Headquarters & Area Served Table 21. Global Lung AI-assisted Diagnosis Software Players, Product Type & Application Table 22. Global Lung AI-assisted Diagnosis Software Players Establishment Date Table 23. Global Players Market Concentration Ratio (CR5 and HHI) Table 24. Global Lung AI-assisted Diagnosis Software by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 25. Global Lung AI-assisted Diagnosis Software Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Lung AI-assisted Diagnosis Software Revenue by Type (2021-2026) & (US$ Million) Table 27. Global Lung AI-assisted Diagnosis Software Revenue by Type (2027-2032) & (US$ Million) Table 28. Global Lung AI-assisted Diagnosis Software Revenue Market Share by Type (2021-2026) Table 29. Global Lung AI-assisted Diagnosis Software Revenue Market Share by Type (2027-2032) Table 30. Global Lung AI-assisted Diagnosis Software Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Lung AI-assisted Diagnosis Software Revenue by Application (2021-2026) & (US$ Million) Table 32. Global Lung AI-assisted Diagnosis Software Revenue by Application (2027-2032) & (US$ Million) Table 33. Global Lung AI-assisted Diagnosis Software Revenue Market Share by Application (2021-2026) Table 34. Global Lung AI-assisted Diagnosis Software Revenue Market Share by Application (2027-2032) Table 35. Sense Time Company Information Table 36. Sense Time Business Overview Table 37. Sense Time Lung AI-assisted Diagnosis Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 38. Sense Time Lung AI-assisted Diagnosis Software Product Portfolio Table 39. Sense Time Recent Development Table 40. United Imaging Company Information Table 41. United Imaging Business Overview Table 42. United Imaging Lung AI-assisted Diagnosis Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 43. United Imaging Lung AI-assisted Diagnosis Software Product Portfolio Table 44. United Imaging Recent Development Table 45. Huiying Medical Company Information Table 46. Huiying Medical Business Overview Table 47. Huiying Medical Lung AI-assisted Diagnosis Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 48. Huiying Medical Lung AI-assisted Diagnosis Software Product Portfolio Table 49. Huiying Medical Recent Development Table 50. Yizhun Company Information Table 51. Yizhun Business Overview Table 52. Yizhun Lung AI-assisted Diagnosis Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 53. Yizhun Lung AI-assisted Diagnosis Software Product Portfolio Table 54. Yizhun Recent Development Table 55. BioMind Company Information Table 56. BioMind Business Overview Table 57. BioMind Lung AI-assisted Diagnosis Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 58. BioMind Lung AI-assisted Diagnosis Software Product Portfolio Table 59. BioMind Recent Development Table 60. Shukun Company Information Table 61. Shukun Business Overview Table 62. Shukun Lung AI-assisted Diagnosis Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 63. Shukun Lung AI-assisted Diagnosis Software Product Portfolio Table 64. Shukun Recent Development Table 65. Infervision Company Information Table 66. Infervision Business Overview Table 67. Infervision Lung AI-assisted Diagnosis Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 68. Infervision Lung AI-assisted Diagnosis Software Product Portfolio Table 69. Infervision Recent Development Table 70. Deepwise Company Information Table 71. Deepwise Business Overview Table 72. Deepwise Lung AI-assisted Diagnosis Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 73. Deepwise Lung AI-assisted Diagnosis Software Product Portfolio Table 74. Deepwise Recent Development Table 75. Optellum Company Information Table 76. Optellum Business Overview Table 77. Optellum Lung AI-assisted Diagnosis Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 78. Optellum Lung AI-assisted Diagnosis Software Product Portfolio Table 79. Optellum Recent Development Table 80. IMLINCS Company Information Table 81. IMLINCS Business Overview Table 82. IMLINCS Lung AI-assisted Diagnosis Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 83. IMLINCS Lung AI-assisted Diagnosis Software Product Portfolio Table 84. IMLINCS Recent Development Table 85. NeuMiva Company Information Table 86. NeuMiva Business Overview Table 87. NeuMiva Lung AI-assisted Diagnosis Software Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 88. NeuMiva Lung AI-assisted Diagnosis Software Product Portfolio Table 89. NeuMiva Recent Development Table 90. Yitu Company Information Table 91. Yitu Business Overview Table 92. Yitu Lung AI-assisted Diagnosis Software Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 93. Yitu Lung AI-assisted Diagnosis Software Product Portfolio Table 94. Yitu Recent Development Table 95. FOSUN AITROX Company Information Table 96. FOSUN AITROX Business Overview Table 97. FOSUN AITROX Lung AI-assisted Diagnosis Software Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 98. FOSUN AITROX Lung AI-assisted Diagnosis Software Product Portfolio Table 99. FOSUN AITROX Recent Development Table 100. VoxelCloud Company Information Table 101. VoxelCloud Business Overview Table 102. VoxelCloud Lung AI-assisted Diagnosis Software Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 103. VoxelCloud Lung AI-assisted Diagnosis Software Product Portfolio Table 104. VoxelCloud Recent Development Table 105. North America Lung AI-assisted Diagnosis Software Revenue by Type (2021-2026) & (US$ Million) Table 106. North America Lung AI-assisted Diagnosis Software Revenue by Type (2027-2032) & (US$ Million) Table 107. North America Lung AI-assisted Diagnosis Software Revenue by Application (2021-2026) & (US$ Million) Table 108. North America Lung AI-assisted Diagnosis Software Revenue by Application (2027-2032) & (US$ Million) Table 109. North America Lung AI-assisted Diagnosis Software Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 110. North America Lung AI-assisted Diagnosis Software Revenue by Country (2021-2026) & (US$ Million) Table 111. North America Lung AI-assisted Diagnosis Software Revenue by Country (US$ Million) & (2027-2032) Table 112. Europe Lung AI-assisted Diagnosis Software Revenue by Type (2021-2026) & (US$ Million) Table 113. Europe Lung AI-assisted Diagnosis Software Revenue by Type (2027-2032) & (US$ Million) Table 114. Europe Lung AI-assisted Diagnosis Software Revenue by Application (2021-2026) & (US$ Million) Table 115. Europe Lung AI-assisted Diagnosis Software Revenue by Application (2027-2032) & (US$ Million) Table 116. Europe Lung AI-assisted Diagnosis Software Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 117. Europe Lung AI-assisted Diagnosis Software Revenue by Country (2021-2026) & (US$ Million) Table 118. Europe Lung AI-assisted Diagnosis Software Revenue by Country (US$ Million) & (2027-2032) Table 119. China Lung AI-assisted Diagnosis Software Revenue by Type (2021-2026) & (US$ Million) Table 120. China Lung AI-assisted Diagnosis Software Revenue by Type (2027-2032) & (US$ Million) Table 121. China Lung AI-assisted Diagnosis Software Revenue by Application (2021-2026) & (US$ Million) Table 122. China Lung AI-assisted Diagnosis Software Revenue by Application (2027-2032) & (US$ Million) Table 123. Asia Lung AI-assisted Diagnosis Software Revenue by Type (2021-2026) & (US$ Million) Table 124. Asia Lung AI-assisted Diagnosis Software Revenue by Type (2027-2032) & (US$ Million) Table 125. Asia Lung AI-assisted Diagnosis Software Revenue by Application (2021-2026) & (US$ Million) Table 126. Asia Lung AI-assisted Diagnosis Software Revenue by Application (2027-2032) & (US$ Million) Table 127. Asia Lung AI-assisted Diagnosis Software Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 128. Asia Lung AI-assisted Diagnosis Software Revenue by Region (US$ Million) & (2021-2026) Table 129. Asia Lung AI-assisted Diagnosis Software Revenue by Region (US$ Million) & (2027-2032) Table 130. SAMEA Lung AI-assisted Diagnosis Software Revenue by Type (2021-2026) & (US$ Million) Table 131. SAMEA Lung AI-assisted Diagnosis Software Revenue by Type (2027-2032) & (US$ Million) Table 132. SAMEA Lung AI-assisted Diagnosis Software Revenue by Application (2021-2026) & (US$ Million) Table 133. SAMEA Lung AI-assisted Diagnosis Software Revenue by Application (2027-2032) & (US$ Million) Table 134. SAMEA Lung AI-assisted Diagnosis Software Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 135. SAMEA Lung AI-assisted Diagnosis Software Revenue by Country (2021-2026) & (US$ Million) Table 136. SAMEA Lung AI-assisted Diagnosis Software Revenue by Country (US$ Million) & (2027-2032) Table 137. Research Programs/Design for This Report Table 138. Authors List of This Report Table 139. Secondary Sources Table 140. Primary Sources List of Figures Figure 1. Lung AI-assisted Diagnosis Software Image Figure 2. Global Lung AI-assisted Diagnosis Software Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Lung AI-assisted Diagnosis Software Market Size Share 2021 VS 2025 VS 2032 Figure 4. Public Cloud Image Figure 5. Private Cloud Image Figure 6. Global Lung AI-assisted Diagnosis Software Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Lung AI-assisted Diagnosis Software Market Size Share 2021 VS 2025 VS 2032 Figure 8. Hospital Image Figure 9. Clinic Image Figure 10. Imaging Center Image Figure 11. Global Lung AI-assisted Diagnosis Software Market Size (US$ Million) & (2021-2032) Figure 12. Global Lung AI-assisted Diagnosis Software Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global Lung AI-assisted Diagnosis Software Market Share by Region: 2021 VS 2025 VS 2032 Figure 14. Global Lung AI-assisted Diagnosis Software Players Revenue Share Top 10 and Top 5 in 2025 Figure 15. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 16. Global Lung AI-assisted Diagnosis Software Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Lung AI-assisted Diagnosis Software Revenue Market Share 2021 VS 2025 VS 2032 Figure 18. Global Lung AI-assisted Diagnosis Software Revenue Market Share by Type (2021-2032) Figure 19. Global Lung AI-assisted Diagnosis Software Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 20. Global Lung AI-assisted Diagnosis Software Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 21. Global Lung AI-assisted Diagnosis Software Revenue Market Share by Application (2021-2032) Figure 22. North America Lung AI-assisted Diagnosis Software Revenue YoY Growth (2021-2032) & (US$ Million) Figure 23. North America Lung AI-assisted Diagnosis Software Revenue Share by Type (2021-2032) Figure 24. North America Lung AI-assisted Diagnosis Software Revenue Share by Application (2021-2032) Figure 25. North America Lung AI-assisted Diagnosis Software Revenue Share by Country (2021-2032) Figure 26. United States Lung AI-assisted Diagnosis Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 27. Canada Lung AI-assisted Diagnosis Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 28. Mexico Lung AI-assisted Diagnosis Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Europe Lung AI-assisted Diagnosis Software Revenue YoY Growth (2021-2032) & (US$ Million) Figure 30. Europe Lung AI-assisted Diagnosis Software Revenue Share by Type (2021-2032) Figure 31. Europe Lung AI-assisted Diagnosis Software Revenue Share by Application (2021-2032) Figure 32. Europe Lung AI-assisted Diagnosis Software Revenue Share by Country (2021-2032) Figure 33. Germany Lung AI-assisted Diagnosis Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 34. France Lung AI-assisted Diagnosis Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 35. U.K. Lung AI-assisted Diagnosis Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. Italy Lung AI-assisted Diagnosis Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. Spain Lung AI-assisted Diagnosis Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Russia Lung AI-assisted Diagnosis Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Netherlands Lung AI-assisted Diagnosis Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Nordic Countries Lung AI-assisted Diagnosis Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. China Lung AI-assisted Diagnosis Software Revenue YoY Growth (2021-2032) & (US$ Million) Figure 42. China Lung AI-assisted Diagnosis Software Revenue Share by Type (2021-2032) Figure 43. China Lung AI-assisted Diagnosis Software Revenue Share by Application (2021-2032) Figure 44. Asia Lung AI-assisted Diagnosis Software Revenue YoY Growth (2021-2032) & (US$ Million) Figure 45. Asia Lung AI-assisted Diagnosis Software Revenue Share by Type (2021-2032) Figure 46. Asia Lung AI-assisted Diagnosis Software Revenue Share by Application (2021-2032) Figure 47. Asia Lung AI-assisted Diagnosis Software Revenue Share by Region (2021-2032) Figure 48. Japan Lung AI-assisted Diagnosis Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 49. South Korea Lung AI-assisted Diagnosis Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 50. India Lung AI-assisted Diagnosis Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. Australia Lung AI-assisted Diagnosis Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. Taiwan Lung AI-assisted Diagnosis Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Southeast Asia Lung AI-assisted Diagnosis Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. SAMEA Lung AI-assisted Diagnosis Software Revenue YoY Growth (2021-2032) & (US$ Million) Figure 55. SAMEA Lung AI-assisted Diagnosis Software Revenue Share by Type (2021-2032) Figure 56. SAMEA Lung AI-assisted Diagnosis Software Revenue Share by Application (2021-2032) Figure 57. SAMEA Lung AI-assisted Diagnosis Software Revenue Share by Country (2021-2032) Figure 58. Brazil Lung AI-assisted Diagnosis Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 59. Argentina Lung AI-assisted Diagnosis Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 60. Chile Lung AI-assisted Diagnosis Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Colombia Lung AI-assisted Diagnosis Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Peru Lung AI-assisted Diagnosis Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Saudi Arabia Lung AI-assisted Diagnosis Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Israel Lung AI-assisted Diagnosis Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. UAE Lung AI-assisted Diagnosis Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Turkey Lung AI-assisted Diagnosis Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Iran Lung AI-assisted Diagnosis Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Egypt Lung AI-assisted Diagnosis Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Public Cloud
  • Private Cloud
Applications
  • Hospital
  • Clinic
  • Imaging Center
Companies covered
  • Sense Time
  • United Imaging
  • Huiying Medical
  • Yizhun
  • BioMind
  • Shukun
  • Infervision
  • Deepwise
  • Optellum
  • IMLINCS
  • NeuMiva
  • Yitu
  • FOSUN AITROX
  • VoxelCloud

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Lung AI-assisted Diagnosis Software Market by Type
  3. 1.2.1 Global Lung AI-assisted Diagnosis Software Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Public Cloud
  5. 1.2.3 Private Cloud
  6. 1.3 Lung AI-assisted Diagnosis Software Market by Application
  7. 1.3.1 Global Lung AI-assisted Diagnosis Software Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Hospital
  9. 1.3.3 Clinic
  10. 1.3.4 Imaging Center
  11. 1.4 Assumptions and Limitations
  12. 1.5 Study Goals and Objectives
2 Lung AI-assisted Diagnosis Software Market Dynamics
  1. 2.1 Lung AI-assisted Diagnosis Software Industry Trends
  2. 2.2 Lung AI-assisted Diagnosis Software Industry Drivers
  3. 2.3 Lung AI-assisted Diagnosis Software Industry Opportunities and Challenges
  4. 2.4 Lung AI-assisted Diagnosis Software Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Lung AI-assisted Diagnosis Software Market Perspective (2021-2032)
  2. 3.2 Global Lung AI-assisted Diagnosis Software Growth Trends by Region
  3. 3.2.1 Global Lung AI-assisted Diagnosis Software Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Lung AI-assisted Diagnosis Software Market Size by Region (2021-2026)
  5. 3.2.3 Global Lung AI-assisted Diagnosis Software Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Lung AI-assisted Diagnosis Software Revenue by Players
  2. 4.1.1 Global Lung AI-assisted Diagnosis Software Revenue by Players (2021-2026)
  3. 4.1.2 Global Lung AI-assisted Diagnosis Software Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Lung AI-assisted Diagnosis Software Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Lung AI-assisted Diagnosis Software Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Lung AI-assisted Diagnosis Software Key Players Headquarters & Area Served
  7. 4.4 Global Lung AI-assisted Diagnosis Software Players, Product Type & Application
  8. 4.5 Global Lung AI-assisted Diagnosis Software Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Lung AI-assisted Diagnosis Software Market CR5 and HHI
  11. 4.6.3 2025 Lung AI-assisted Diagnosis Software Tier 1, Tier 2, and Tier 3
5 Lung AI-assisted Diagnosis Software Market Size by Type
  1. 5.1 Global Lung AI-assisted Diagnosis Software Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Lung AI-assisted Diagnosis Software Revenue by Type (2021-2032)
  3. 5.3 Global Lung AI-assisted Diagnosis Software Revenue Market Share by Type (2021-2032)
6 Lung AI-assisted Diagnosis Software Market Size by Application
  1. 6.1 Global Lung AI-assisted Diagnosis Software Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Lung AI-assisted Diagnosis Software Revenue by Application (2021-2032)
  3. 6.3 Global Lung AI-assisted Diagnosis Software Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Sense Time
  2. 7.1.1 Sense Time Company Information
  3. 7.1.2 Sense Time Business Overview
  4. 7.1.3 Sense Time Lung AI-assisted Diagnosis Software Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Sense Time Lung AI-assisted Diagnosis Software Product Portfolio
  6. 7.1.5 Sense Time Recent Developments
  7. 7.2 United Imaging
  8. 7.2.1 United Imaging Company Information
  9. 7.2.2 United Imaging Business Overview
  10. 7.2.3 United Imaging Lung AI-assisted Diagnosis Software Revenue and Gross Margin (2021-2026)
  11. 7.2.4 United Imaging Lung AI-assisted Diagnosis Software Product Portfolio
  12. 7.2.5 United Imaging Recent Developments
  13. 7.3 Huiying Medical
  14. 7.3.1 Huiying Medical Company Information
  15. 7.3.2 Huiying Medical Business Overview
  16. 7.3.3 Huiying Medical Lung AI-assisted Diagnosis Software Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Huiying Medical Lung AI-assisted Diagnosis Software Product Portfolio
  18. 7.3.5 Huiying Medical Recent Developments
  19. 7.4 Yizhun
  20. 7.4.1 Yizhun Company Information
  21. 7.4.2 Yizhun Business Overview
  22. 7.4.3 Yizhun Lung AI-assisted Diagnosis Software Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Yizhun Lung AI-assisted Diagnosis Software Product Portfolio
  24. 7.4.5 Yizhun Recent Developments
  25. 7.5 BioMind
  26. 7.5.1 BioMind Company Information
  27. 7.5.2 BioMind Business Overview
  28. 7.5.3 BioMind Lung AI-assisted Diagnosis Software Revenue and Gross Margin (2021-2026)
  29. 7.5.4 BioMind Lung AI-assisted Diagnosis Software Product Portfolio
  30. 7.5.5 BioMind Recent Developments
  31. 7.6 Shukun
  32. 7.6.1 Shukun Company Information
  33. 7.6.2 Shukun Business Overview
  34. 7.6.3 Shukun Lung AI-assisted Diagnosis Software Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Shukun Lung AI-assisted Diagnosis Software Product Portfolio
  36. 7.6.5 Shukun Recent Developments
  37. 7.7 Infervision
  38. 7.7.1 Infervision Company Information
  39. 7.7.2 Infervision Business Overview
  40. 7.7.3 Infervision Lung AI-assisted Diagnosis Software Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Infervision Lung AI-assisted Diagnosis Software Product Portfolio
  42. 7.7.5 Infervision Recent Developments
  43. 7.8 Deepwise
  44. 7.8.1 Deepwise Company Information
  45. 7.8.2 Deepwise Business Overview
  46. 7.8.3 Deepwise Lung AI-assisted Diagnosis Software Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Deepwise Lung AI-assisted Diagnosis Software Product Portfolio
  48. 7.8.5 Deepwise Recent Developments
  49. 7.9 Optellum
  50. 7.9.1 Optellum Company Information
  51. 7.9.2 Optellum Business Overview
  52. 7.9.3 Optellum Lung AI-assisted Diagnosis Software Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Optellum Lung AI-assisted Diagnosis Software Product Portfolio
  54. 7.9.5 Optellum Recent Developments
  55. 7.10 IMLINCS
  56. 7.10.1 IMLINCS Company Information
  57. 7.10.2 IMLINCS Business Overview
  58. 7.10.3 IMLINCS Lung AI-assisted Diagnosis Software Revenue and Gross Margin (2021-2026)
  59. 7.10.4 IMLINCS Lung AI-assisted Diagnosis Software Product Portfolio
  60. 7.10.5 IMLINCS Recent Developments
  61. 7.11 NeuMiva
  62. 7.11.1 NeuMiva Company Information
  63. 7.11.2 NeuMiva Business Overview
  64. 7.11.3 NeuMiva Lung AI-assisted Diagnosis Software Revenue and Gross Margin (2021-2026)
  65. 7.11.4 NeuMiva Lung AI-assisted Diagnosis Software Product Portfolio
  66. 7.11.5 NeuMiva Recent Developments
  67. 7.12 Yitu
  68. 7.12.1 Yitu Company Information
  69. 7.12.2 Yitu Business Overview
  70. 7.12.3 Yitu Lung AI-assisted Diagnosis Software Revenue and Gross Margin (2021-2026)
  71. 7.12.4 Yitu Lung AI-assisted Diagnosis Software Product Portfolio
  72. 7.12.5 Yitu Recent Developments
  73. 7.13 FOSUN AITROX
  74. 7.13.1 FOSUN AITROX Company Information
  75. 7.13.2 FOSUN AITROX Business Overview
  76. 7.13.3 FOSUN AITROX Lung AI-assisted Diagnosis Software Revenue and Gross Margin (2021-2026)
  77. 7.13.4 FOSUN AITROX Lung AI-assisted Diagnosis Software Product Portfolio
  78. 7.13.5 FOSUN AITROX Recent Developments
  79. 7.14 VoxelCloud
  80. 7.14.1 VoxelCloud Company Information
  81. 7.14.2 VoxelCloud Business Overview
  82. 7.14.3 VoxelCloud Lung AI-assisted Diagnosis Software Revenue and Gross Margin (2021-2026)
  83. 7.14.4 VoxelCloud Lung AI-assisted Diagnosis Software Product Portfolio
  84. 7.14.5 VoxelCloud Recent Developments
8 North America
  1. 8.1 North America Lung AI-assisted Diagnosis Software Revenue (2021-2032)
  2. 8.2 North America Lung AI-assisted Diagnosis Software Revenue by Type (2021-2032)
  3. 8.2.1 North America Lung AI-assisted Diagnosis Software Revenue by Type (2021-2026)
  4. 8.2.2 North America Lung AI-assisted Diagnosis Software Revenue by Type (2027-2032)
  5. 8.3 North America Lung AI-assisted Diagnosis Software Revenue Share by Type (2021-2032)
  6. 8.4 North America Lung AI-assisted Diagnosis Software Revenue by Application (2021-2032)
  7. 8.4.1 North America Lung AI-assisted Diagnosis Software Revenue by Application (2021-2026)
  8. 8.4.2 North America Lung AI-assisted Diagnosis Software Revenue by Application (2027-2032)
  9. 8.5 North America Lung AI-assisted Diagnosis Software Revenue Share by Application (2021-2032)
  10. 8.6 North America Lung AI-assisted Diagnosis Software Revenue by Country
  11. 8.6.1 North America Lung AI-assisted Diagnosis Software Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Lung AI-assisted Diagnosis Software Revenue by Country (2021-2026)
  13. 8.6.3 North America Lung AI-assisted Diagnosis Software Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Lung AI-assisted Diagnosis Software Revenue (2021-2032)
  2. 9.2 Europe Lung AI-assisted Diagnosis Software Revenue by Type (2021-2032)
  3. 9.2.1 Europe Lung AI-assisted Diagnosis Software Revenue by Type (2021-2026)
  4. 9.2.2 Europe Lung AI-assisted Diagnosis Software Revenue by Type (2027-2032)
  5. 9.3 Europe Lung AI-assisted Diagnosis Software Revenue Share by Type (2021-2032)
  6. 9.4 Europe Lung AI-assisted Diagnosis Software Revenue by Application (2021-2032)
  7. 9.4.1 Europe Lung AI-assisted Diagnosis Software Revenue by Application (2021-2026)
  8. 9.4.2 Europe Lung AI-assisted Diagnosis Software Revenue by Application (2027-2032)
  9. 9.5 Europe Lung AI-assisted Diagnosis Software Revenue Share by Application (2021-2032)
  10. 9.6 Europe Lung AI-assisted Diagnosis Software Revenue by Country
  11. 9.6.1 Europe Lung AI-assisted Diagnosis Software Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Lung AI-assisted Diagnosis Software Revenue by Country (2021-2026)
  13. 9.6.3 Europe Lung AI-assisted Diagnosis Software Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Lung AI-assisted Diagnosis Software Revenue (2021-2032)
  2. 10.2 China Lung AI-assisted Diagnosis Software Revenue by Type (2021-2032)
  3. 10.2.1 China Lung AI-assisted Diagnosis Software Revenue by Type (2021-2026)
  4. 10.2.2 China Lung AI-assisted Diagnosis Software Revenue by Type (2027-2032)
  5. 10.3 China Lung AI-assisted Diagnosis Software Revenue Share by Type (2021-2032)
  6. 10.4 China Lung AI-assisted Diagnosis Software Revenue by Application (2021-2032)
  7. 10.4.1 China Lung AI-assisted Diagnosis Software Revenue by Application (2021-2026)
  8. 10.4.2 China Lung AI-assisted Diagnosis Software Revenue by Application (2027-2032)
  9. 10.5 China Lung AI-assisted Diagnosis Software Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Lung AI-assisted Diagnosis Software Revenue (2021-2032)
  2. 11.2 Asia Lung AI-assisted Diagnosis Software Revenue by Type (2021-2032)
  3. 11.2.1 Asia Lung AI-assisted Diagnosis Software Revenue by Type (2021-2026)
  4. 11.2.2 Asia Lung AI-assisted Diagnosis Software Revenue by Type (2027-2032)
  5. 11.3 Asia Lung AI-assisted Diagnosis Software Revenue Share by Type (2021-2032)
  6. 11.4 Asia Lung AI-assisted Diagnosis Software Revenue by Application (2021-2032)
  7. 11.4.1 Asia Lung AI-assisted Diagnosis Software Revenue by Application (2021-2026)
  8. 11.4.2 Asia Lung AI-assisted Diagnosis Software Revenue by Application (2027-2032)
  9. 11.5 Asia Lung AI-assisted Diagnosis Software Revenue Share by Application (2021-2032)
  10. 11.6 Asia Lung AI-assisted Diagnosis Software Revenue by Country
  11. 11.6.1 Asia Lung AI-assisted Diagnosis Software Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Lung AI-assisted Diagnosis Software Revenue by Country (2021-2026)
  13. 11.6.3 Asia Lung AI-assisted Diagnosis Software Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Lung AI-assisted Diagnosis Software Revenue (2021-2032)
  2. 12.2 SAMEA Lung AI-assisted Diagnosis Software Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Lung AI-assisted Diagnosis Software Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Lung AI-assisted Diagnosis Software Revenue by Type (2027-2032)
  5. 12.3 SAMEA Lung AI-assisted Diagnosis Software Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Lung AI-assisted Diagnosis Software Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Lung AI-assisted Diagnosis Software Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Lung AI-assisted Diagnosis Software Revenue by Application (2027-2032)
  9. 12.5 SAMEA Lung AI-assisted Diagnosis Software Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Lung AI-assisted Diagnosis Software Revenue by Country
  11. 12.6.1 SAMEA Lung AI-assisted Diagnosis Software Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Lung AI-assisted Diagnosis Software Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Lung AI-assisted Diagnosis Software Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst